192 related articles for article (PubMed ID: 25996419)
1. Evaluation of Effect of Topical Tacrolimus Treatment on Herpetic Stromal Keratitis in a Rat Model.
Eriş E; Yüksel N; Pirhan D; Karadenizli A; Aslan M; Gacar G; Erman G; Subaş C; Uzuner H; Yldz DK; Karaöz E
Eye Contact Lens; 2016 May; 42(3):163-70. PubMed ID: 25996419
[TBL] [Abstract][Full Text] [Related]
2. Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model.
Yoon KC; Heo H; Kang IS; Lee MC; Kim KK; Park SH; Cho KO
Cornea; 2008 May; 27(4):454-60. PubMed ID: 18434850
[TBL] [Abstract][Full Text] [Related]
3. Topical cyclosporine-A versus prednisolone for herpetic stromal keratitis: a randomized controlled trial.
Peyman A; Nayebzadeh M; Peyman M; Afshari NA; Pourazizi M
Acta Ophthalmol; 2019 Mar; 97(2):e194-e198. PubMed ID: 30284385
[TBL] [Abstract][Full Text] [Related]
4. Blockade of IL-27 signaling ameliorates herpes stromal keratitis with upregulated CD4
Xia L; Tan T; Li Y; Zhong Q; Shi M
Indian J Ophthalmol; 2019 Nov; 67(11):1821-1828. PubMed ID: 31638041
[TBL] [Abstract][Full Text] [Related]
5. Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%.
Rao SN
Am J Ophthalmol; 2006 Apr; 141(4):771-2. PubMed ID: 16564829
[TBL] [Abstract][Full Text] [Related]
6. Herpetic Eye Disease Study: A Controlled Trial of Topical Corticosteroids for Herpes Simplex Stromal Keratitis.
Wilhelmus KR; Gee L; Hauck WW; Kurinij N; Dawson CR; Jones DB; Barron BA; Kaufman HE; Sugar J; Hyndiuk RA; Laibson PR; Stulting RD; Asbell PA;
Ophthalmology; 2020 Apr; 127(4S):S5-S18. PubMed ID: 32200827
[TBL] [Abstract][Full Text] [Related]
7. Modalities to decrease stromal herpes simplex keratitis reactivation rates.
Sheppard JD; Wertheimer ML; Scoper SV
Arch Ophthalmol; 2009 Jul; 127(7):852-6. PubMed ID: 19597103
[TBL] [Abstract][Full Text] [Related]
8. HSV-1 antigens and DNA in the corneal explant buttons of patients with non-herpetic or clinically atypical herpetic stromal keratitis.
Garweg JG; Russ CE; Schellhorn M; Böhnke M; Halberstadt M
Graefes Arch Clin Exp Ophthalmol; 2003 Sep; 241(9):734-9. PubMed ID: 12827375
[TBL] [Abstract][Full Text] [Related]
9. Topical antisense-oligonucleotides targeting IFN-gamma mRNA improve incidence and severity of herpetic stromal keratitis by cytokine specific and sequence unspecific effects.
Wasmuth S; Bauer D; Steuhl KP; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):443-51. PubMed ID: 18030487
[TBL] [Abstract][Full Text] [Related]
10. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice.
Lepisto AJ; Frank GM; Xu M; Stuart PM; Hendricks RL
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3400-9. PubMed ID: 16877409
[TBL] [Abstract][Full Text] [Related]
11. Sensory Nerve Retraction and Sympathetic Nerve Innervation Contribute to Immunopathology of Murine Recurrent Herpes Stromal Keratitis.
Yun H; Yin XT; Stuart PM; St Leger AJ
Invest Ophthalmol Vis Sci; 2022 Feb; 63(2):4. PubMed ID: 35103749
[TBL] [Abstract][Full Text] [Related]
12. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes.
Doymaz MZ; Rouse BT
Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2165-73. PubMed ID: 1351475
[TBL] [Abstract][Full Text] [Related]
13. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis.
Banerjee K; Biswas PS; Rouse BT
J Leukoc Biol; 2005 Jan; 77(1):24-32. PubMed ID: 15496448
[TBL] [Abstract][Full Text] [Related]
14. Substance P in the corneal stroma regulates the severity of herpetic stromal keratitis lesions.
Twardy BS; Channappanavar R; Suvas S
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8604-13. PubMed ID: 21969295
[TBL] [Abstract][Full Text] [Related]
15. Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis.
Gündüz K; Ozdemir O
Ophthalmic Res; 1997; 29(6):405-8. PubMed ID: 9380342
[TBL] [Abstract][Full Text] [Related]
16. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study.
Heiligenhaus A; Steuhl KP
Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):435-8. PubMed ID: 10333113
[TBL] [Abstract][Full Text] [Related]
17. CD4(+) and CD8(+) cells are key participants in the development of recurrent herpetic stromal keratitis in mice.
Keadle TL; Morris JL; Pepose JS; Stuart PM
Microb Pathog; 2002 Jun; 32(6):255-62. PubMed ID: 12137752
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
[TBL] [Abstract][Full Text] [Related]
19. Management of Stromal Herpes Simplex Virus Keratitis With Epithelial Ulceration Using Optical Coherence Tomography-Generated Corneal Thickness Maps.
Lu L; Palioura S
Cornea; 2020 Dec; 39(12):1566-1570. PubMed ID: 33170587
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of herpetic stromal keratitis in CCR5- and/or CXCR3-deficient mice.
Komatsu K; Miyazaki D; Morohoshi K; Kuo CH; Kakimaru-Hasegawa A; Komatsu N; Namba S; Haino M; Matsushima K; Inoue Y
Curr Eye Res; 2008 Sep; 33(9):736-49. PubMed ID: 18798077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
